Developing a vaccine to protect against antibiotic-resistant Acinetobacter baumannii infections
A Subunit Vaccine Against Acinetobacter Baumannii
This study is working on a new vaccine to help protect people from tough infections caused by a bacteria called Multi-Drug Resistant Acinetobacter baumannii, which is a big concern in hospitals.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Biological Mimetics, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-11068597 on NIH RePORTER |
What this research studies
This research focuses on creating a new vaccine to combat Multi-Drug Resistant Acinetobacter baumannii (MDR-AB), a significant threat to global health. The project aims to identify key components of the bacteria that can stimulate a strong immune response, develop a prototype vaccine formulation, and evaluate its effectiveness through laboratory tests. By using advanced immunological techniques and molecular biology tools, the researchers hope to provide a preventive measure against these dangerous infections, which are particularly prevalent in healthcare settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for MDR-AB infections, such as patients in hospitals or those with compromised immune systems.
Not a fit: Patients who are not at risk for antibiotic-resistant infections or those who are not currently in healthcare settings may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a vaccine that significantly reduces the incidence of MDR-AB infections and reliance on antibiotics.
How similar studies have performed: While the approach of developing a vaccine against MDR-AB is innovative, similar efforts in vaccine development against other antibiotic-resistant bacteria have shown promise, indicating potential for success.
Where this research is happening
Frederick, United States
- Biological Mimetics, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Dollery, Stephen Jeffrey — Biological Mimetics, INC.
- Study coordinator: Dollery, Stephen Jeffrey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.